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Introduction 
Epidemiologic studies have reported an increased risk of breast cancer among women 
who drink alcohol, including wine (1, 2) Two meta-analyses estimated a ~10% (95% CI 5%, 
15%) increased risk of breast cancer with each additional 10g (~1 drink) of alcohol/day 
regardless of beverage type (3, 4). Few studies have evaluated breast cancer risk separately for 
red and white wine (5-8). There is some evidence of beneficial health effects of red wine from 
laboratory (9) and epidemiological studies of heart disease (10) and prostate cancer (11, 12). 
We evaluated overall alcohol as well as red and white wine consumption to examine beverage-
specific effects on breast cancer. 
Methods 
 The analysis was conducted in a population-based case-control study described fully 
elsewhere (13).  Briefly, the study enrolled breast cancer cases identified from population-based 
registries in Wisconsin, Massachusetts (excluding metropolitan Boston), and New Hampshire, 
age 20-69 years, with incident invasive breast cancer diagnosed between 1995 and 2000.  
Controls were frequency matched to cases by 5-year age groups, selected from lists of licensed 
drivers (<65 years) or a roster of Medicare beneficiaries (≥ 65 years).  Approximately 80% of 
cases (n=6,327) and 76% of controls (n=7,558) participated in the study; participation was 
similar in the three states.   
 Telephone interviews were administered concurrently for case (typically within one year 
of diagnosis) and control participants.  Participants were queried on suspected risk factors for 
breast cancer, including age at menarche and menopause, age at first pregnancy, parity, 
postmenopausal hormone use, family history of breast cancer, smoking, education, and body 
mass index evaluated prior to the reference date.  Alcohol use was evaluated as frequency of 
beer, red wine, white wine, or liquor (distilled spirits) consumption (number of drinks per day, 
week, or month) during the year previous to the reference date, defined as the date of diagnosis 
for cases or approximately the same period for controls.  Logistic regression was used to 
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estimate odds ratios (OR) and 95% confidence intervals (CI).  Variables were included in the 
multivariable model if statistically significantly associated with breast cancer (P ≤ 0.05) in age-
adjusted models.  Models estimating the effect of wine type on risk were adjusted for all other 
sources of alcohol.  To obtain P-values for trend, we included alcohol both as a continuous and 
categorical exposure.  We tested for interaction by type of alcohol.  Analyses were conducted 
using SAS (Version 9.1, SAS Institute, Cary, NC). 
Results 
Cases tended to have a younger age at menarche, later age at first birth, lower parity, 
and later age at menopause (data not shown).  Current use of postmenopausal hormones, first-
degree family history of breast cancer, greater body mass index, and higher education were 
also associated with increased breast cancer.   
Any alcohol consumption in the year before the reference date was reported by similar 
proportions of cases (82%) and controls (82%).  After multivariable adjustment, consumption of 
14 or more drinks per week was associated with a 24% increase in breast cancer (95% CI: 3%-
49%, P for trend= 0.003) compared to non-drinkers (Table 1). Menopausal status modified this 
association, with elevated risk observed only among postmenopausal women (P for interaction= 
0.05). This effect this was driven by a statistical interaction only among liquor drinkers. Higher 
intake of all beverage types was suggestive of increased risk, only elevated consumption of 
liquor was significantly elevated per drink (OR=1.02, 95% CI= 1.00 to 1.03).  Wine consumption 
was not associated with risk of breast cancer (OR=1.01, 95% CI=0.99 to 1.02) and no 
differential was observed between red and white wine (P=0.6 for interaction, Table 2).   
Discussion 
In this large, multi-center, population-based case control study, alcohol was associated 
with an elevated risk of breast cancer, primarily because of increased risk in postmenopausal 
liquor drinkers. Neither red nor while wine was related to breast cancer.   
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 The Women’s Health Study, a randomized, chemopreventive trial of 39,876 health 
professionals followed for ~10 years, reported similar associations of white (multivariable RR 
1.1, 95% CI 0.9-1.2) and red (multivariable RR 1.0, 95% CI 0.8-1.2) wine per 10 g/day 
increment on risk of breast cancer (6).   Further, two other studies conducted in France reported 
findings that did not support inverse effects of red wine versus white wine.  Hirvonen et al  
reported no significantly increased risk of breast cancer associated with either red or white wine 
after a median 6.6 years follow-up in a placebo-controlled antioxidant primary-prevention trial (8) 
with 95 breast cancer cases.  A small case-control study of premenopausal women (n=154 
cases and 154 controls) reported an increase in breast cancer for women who reported 
consuming more than 4 liters of red wine per month, or ~1 drink/day (OR=4.0; 95% CI 1.6-9.8; 
P-trend=0.003) (5).  Whereas over half of the study population consumed red wine, <10% 
reported consuming white wine (5).  This differs from our study where equal proportions of 
women reported consuming red and white wine. Another case-control study conducted in 
France reported a lower risk of breast cancer among women consuming 10 -12 g/d of wine 
(OR=0.51; 95% CI=0.30-0.97) when compared with non-wine drinkers, but they did not evaluate 
red and white wine separately(14). 
Separate effects of red versus white wine on risk may have biological plausibility. 
Resveratrol, a polyphenol in grapes, peanuts, and other plant-based foods, has displayed anti-
carcinogenic properties in mouse mammary cultures (15, 16). Concentrations are greater in red 
compared to white wine, due to the variable amounts of time that red grape skins are present 
during processing (17).  However, resveratrol is metabolized quickly: consistent intake of two 
glasses of red wine daily would be equivalent to a dose of ~27 µg/kg body weight for a 70 kg 
individual, leading to detectable concentrations of derivatives but not free resveratrol (9).  Thus 
these low levels may not result in bioeffective concentrations.  
Limitations should be considered in interpreting findings.  Exposure measurement was 
limited to recent use and patterns may have changed over time. Though we were able to control 
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for many confounders, we did not have data on drinking patterns (i.e. moderate versus binge 
drinking).  Self-reported alcohol intake measures are prone to error due to both retrospective 
reporting and recall bias.  However, alcohol intake measured via food frequency is correlated 
with food records (Spearman r=0.9) (18) and the reliability of reporting is acceptable (r=0.8) 
(19). 
Wine consumption has been increasing over the past decade in the United States (20), 
so future studies may more precisely evaluate the effects red and white wine on incidence of 
breast cancer. 
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Table 1: Association of recent alcoholic beverage consumption and breast cancer risk 
 All Women Premenopausal Women Postmenopausal Women 2,3 
 Cases 
 (n = 6,327) 
Controls 
 (n = 7,558) 
OR1 
 (95% CI) 
Cases 
(n = 2,462) 
Controls 
(n = 2,925) 
OR1  
(95% CI) 
Cases 
 (n =3,449) 
Controls  
(n = 4,162) 
OR1  
(95% CI) 
Drinks per week No. (%) No. (%)  No. (%) No. (%)  No. (%) No. (%)  
All alcohol          
     Non-drinkers 1122 (18) 1379 (18) 1 351 (14) 424 (15) 1 709 (21) 876 (21) 1 
     <1 2129 (34) 2712 (36) 0.94 (0.85-1.04) 894 (36) 1045 (36) 1.02 (0.86-1.22) 1106 (32) 1480 (36) 0.90 (0.79-1.02) 
     1-3.4 1450 (23) 1731 (23) 0.99 (0.88-1.10) 592 (24) 767 (26) 0.90 (0.75-1.08) 745 (22) 863 (21) 1.03 (0.89-1.19) 
     3.5-6.9 702 (11) 793 (11) 1.02 (0.90-1.17) 306 (12) 363 (12) 0.96 (0.78-1.19) 345 (10) 384 (9) 1.05 (0.88-1.26) 
     7-13.9 619 (10) 658 (9) 1.11 (0.97-1.28) 221 (9) 223 (8) 1.17 (0.92-1.48) 355 (10) 395 (10) 1.07 (0.89-1.28) 
     ≥ 14 305 (5) 285 (4) 1.24 (1.03-1.49) 98 (4) 103 (4) 1.10 (0.80-1.52) 189 (6) 164 (4) 1.37 (1.08-1.73) 
       P-trend   0.003   0.55   0.004 
1-drink increase   1.01 (1.00-1.02)   1.00 (0.99-1.01)   1.02 (1.01-1.03) 
Wine          
     Non-drinkers 1122 (18) 1379 (18) 1 351 (14) 424 (15) 1 709 (21) 876 (21) 1 
     <1 2455 (39) 2920 (39) 1.03 (0.94-1.12) 1021 (42) 1183 (40) 1.09 (0.95-1.26) 1283 (37) 1550 (37) 0.97 (0.86-1.09) 
     1-3.4 1048 (17) 1248 (17) 1.00 (0.89-1.11) 424 (17) 546 (19) 0.98 (0.82-1.17) 538 (16) 634 (15) 0.95 (0.81-1.11) 
     3.5-6.9 343 (5) 363 (5) 1.13 (0.95-1.34) 134 (5) 149 (5) 1.15 (0.87-1.50) 179 (5) 192 (5) 1.05 (0.83-1.33) 
     7-13.9 256 (4) 299 (4) 1.07 (0.89-1.29) 90 (4) 86 (3) 1.42 (1.02-1.96) 147 (4) 192 (5) 0.93 (0.73-1.19) 
     ≥ 14 82 (1) 70 (1) 1.37 (0.98-1.91) 29 (1) 24 (1) 1.58 (0.90-2.79) 47 (1) 43 (1) 1.23 (0.80-1.90) 
       P-trend   0.20   0.12   0.84 
1-drink increase   1.01 (0.99-1.02)   1.00 (0.99-1.02)   1.01 (0.99-1.03) 
Beer          
     Non-drinkers 1122 (18) 1379 (18) 1 351 (14) 424 (15) 1 709 (21) 876 (21) 1 
     <1 1756 (28) 2040 (27) 1.01 (0.93-1.10) 714 (29) 870 (30) 0.92 (0.80-1.05) 916 (27) 1044 (25) 1.05 (0.94-1.18) 
     1-3.4 754 (12) 836 (11) 1.06 (0.95-1.20) 359 (15) 444 (15) 0.91 (0.77-1.08) 345 (10) 346 (8) 1.21 (1.02-1.44) 
     3.5-6.9 163 (3) 210 (3) 0.90 (0.72-1.12) 105 (4) 120 (4) 0.91 (0.69-1.21) 48 (1) 76 (2) 0.81 (0.55-1.17) 
     7-13.9 129 (2) 139 (2) 1.08 (0.84-1.39) 52 (2) 55 (2) 1.05 (0.71-1.56) 66 (2) 74 (2) 1.08 (0.76-1.52) 
     ≥ 14  82 (1) 84 (1) 1.12 (0.81-1.53) 32 (1) 39 (1) 0.89 (0.55-1.45) 45 (1) 39 (1) 1.44 (0.92-2.25) 
       P-trend   0.55   0.28   0.11 
1-drink increase   1.01 (1.00-1.02)   1.01 (0.99-1.02)   1.01 (1.00-1.03) 
Liquor          
     Non-drinkers 1122 (18) 1379 (18) 1 351 (14) 424 (15) 1 709 (21) 876 (21) 1 
     <1 2463 (39) 3132 (41) 0.90 (0.83-0.98) 1098 (45) 1371 (47) 0.90 (0.79-1.02) 1186 (34) 1529 (37) 0.93 (0.83-1.04) 
     1-3.4 940 (15) 1044(14) 1.00 (0.90-1.12) 334 (14) 402 (14) 0.92 (0.77-1.11) 541(16) 582 (14) 1.07 (0.92-1.24) 
     3.5-6.9 154 (2) 146 (2) 1.14 (0.90-1.44) 55 (2) 61 (2) 0.93 (0.63-1.37) 93 (3) 75 (2) 1.40 (1.02-1.93) 
     7-13.9 162 (3) 175 (2) 1.00 (0.80-1.26) 37 (2) 38 (1) 1.00 (0.62-1.60) 115 (3) 131 (3) 0.98 (0.75-1.29) 
     ≥ 14 95 (2) 73 (1) 1.41 (1.03-1.94) 18 (1) 19 (1) 1.10 (0.56-2.13) 74 (2) 50 (1) 1.63 (1.12-2.38) 
       P-trend   0.28   0.37   0.04 
1-drink increase   1.02 (1.00-1.03)   0.99 (0.97-1.02)   1.03 (1.01-1.05) 
1 Adjusted for age, state, family history of breast cancer, age at menarche, age at first birth, parity, menopausal status, age at menopause, 
postmenopausal hormone use, body mass index, education, wine, beer and liquor consumption.  
2 For the test of the interaction between total alcohol consumption (continuous) and menopausal status P = 0.05. 
3 For the test of the interaction between alcohol consumption (continuous) and menopausal status: all alcohol P=0.05; wine P=0.89, beer 
P=0.89, liquor P=0.03 
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 Table 2: Association of recent red and white wine consumption and breast cancer risk 
Wine type Cases  Controls  
 (n= 6,327)  (n= 7,558)  
OR (95% CI)1,2 
Drinks per week No. (%)  No. (%)   
Red wine      
     Non-drinkers 1,122 (18)  1,379 (18)  1 
     <1 2,145 (34)  2,502 (33)  1.03 (0.94-1.12) 
     1-3.4 738 (12)  885 (12)  0.94 (0.83-1.06) 
     3.5-6.9 98 (2)  119 (2)  0.91 (0.69-1.21) 
     7-13.9 124 (2)  133 (2)  1.17 (0.90-1.51) 
     ≥14 28 (<1)  24 (<1)  1.27 (0.73-2.22) 
     P-trend     0.99 
     1-drink increase     1.00 (0.98-1.01) 
White wine      
     Non-drinkers 1,122 (18)  1,379 (18)  1 
     <1 2,145 (34)  2,587 (34)  0.98 (0.90-1.07) 
     1-3.4 880 (14)  997 (13)  1.06 (0.94-1.19) 
     3.5-6.9 161 (3)  143 (2)  1.40 (1.10-1.78) 
     7-13.9 103 (2)  137 (2)  0.90 (0.69-1.18) 
     ≥14 40 (1)  34 (<1)  1.37 (0.86-2.19) 
     P-trend     0.34 
     1-drink increase     1.02 (1.00-1.04) 
1 Adjusted for age, state, family history of breast cancer, age at menarche, age at first birth, parity, menopausal 
status, age at menopause, postmenopausal hormone use, body mass index, education, total alcohol 
consumption (minus red or white wine consumption). 
 
2 For the test of the interaction wine type (red vs. white, continuous) P=0.60.  
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